Mostrar el registro sencillo del ítem

Treatment retention and safety of ixekizumab in psoriatic arthritis: a real life single-center experience

dc.contributor.authorBraña, I.
dc.contributor.authorPardo, E.
dc.contributor.authorBurger, S.
dc.contributor.authorGonzález del Pozo, P.
dc.contributor.authorAlperi, M.
dc.contributor.authorQueiro Silva, Rubén 
dc.date.accessioned2023-05-18T08:23:09Z
dc.date.available2023-05-18T08:23:09Z
dc.date.issued2023
dc.identifier.citationJournal of Clinical Medicine, 12(2) (2023); doi:10.3390/jcm12020467
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10651/68293
dc.language.isoeng
dc.relation.ispartofJournal of Clinical Medicine
dc.rights© 2023 Los autores
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85146819127&doi=10.3390%2fjcm12020467&partnerID=40&md5=8aef0f661bc792a8098cc8af010959c9
dc.titleTreatment retention and safety of ixekizumab in psoriatic arthritis: a real life single-center experience
dc.typejournal article
dc.identifier.doi10.3390/jcm12020467
dc.relation.publisherversionhttp://dx.doi.org/10.3390/jcm12020467
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2023 Los autores
Este ítem está sujeto a una licencia Creative Commons